Effect of Inflammatory Microenvironment on the Regenerative Capacity of Adipose-Derived Mesenchymal Stem Cells.
adipose-derived mesenchymal stem cells
inflammation
lipopolysaccharide
regenerative medicine
tumor necrosis factor α
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
29 07 2023
29 07 2023
Historique:
received:
26
05
2023
revised:
12
07
2023
accepted:
22
07
2023
medline:
14
8
2023
pubmed:
11
8
2023
entrez:
11
8
2023
Statut:
epublish
Résumé
Adipose-derived mesenchymal stem cells are increasingly being used in regenerative medicine as cell therapy targets, including in the treatment of burns and ulcers. The regenerative potential of AD-MSCs and some of their immunological properties are known from in vitro studies; however, in clinical applications, cells are used in non-ideal conditions and can behave differently in inflammatory environments, affecting the efficacy and outcome of therapy. Our aim was to investigate and map the pathways that the inflammatory microenvironment can induce in these cells. High-throughput gene expression assays were performed on AD-MSCs activated with LPS and TNFα. Analysis of RNA-Seq data showed that control, LPS-treated and TNFα-treated samples exhibited distinct gene expression patterns. LPS treatment increased the expression of 926 genes and decreased the expression of 770 genes involved in cell division, DNA repair, the cell cycle, and several metabolic processes. TNFα treatment increased the expression of 174 genes and decreased the expression of 383 genes, which are related to cell division, the immune response, cell proliferation, and differentiation. We also map the biological pathways by further investigating the most altered genes using the Gene Ontology and KEGG databases. Secreted cytokines, which are important in the immunological response, were also examined at the protein level, and a functional assay was performed to assess wound healing. Activated AD-MSC increased the secretion of IL-6, IL-8 and CXCL-10, and also the closure of wounds. AD-MSCs presented accelerated wound healing under inflammation conditions, suggesting that we could use this cell in clinical application.
Identifiants
pubmed: 37566046
pii: cells12151966
doi: 10.3390/cells12151966
pmc: PMC10416993
pii:
doi:
Substances chimiques
Tumor Necrosis Factor-alpha
0
Lipopolysaccharides
0
Cytokines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Cell Mol Life Sci. 2019 Sep;76(17):3323-3348
pubmed: 31055643
Arch Physiol Biochem. 2011 May;117(2):47-56
pubmed: 21158485
Immunol Lett. 2015 Dec;168(2):147-53
pubmed: 26073566
Hum Cell. 2023 Jul;36(4):1253-1264
pubmed: 37067766
Cell Transplant. 2020 Jan-Dec;29:963689720945682
pubmed: 32878464
Front Immunol. 2023 Apr 28;14:1111813
pubmed: 37187733
Cells. 2019 Jan 05;8(1):
pubmed: 30621275
Stem Cell Res Ther. 2020 Sep 25;11(1):416
pubmed: 32988406
J Cell Mol Med. 2021 Jun;25(11):5124-5137
pubmed: 33951289
Stem Cells. 2004;22(3):405-14
pubmed: 15153617
Cell Mol Life Sci. 2017 Jul;74(13):2345-2360
pubmed: 28214990
Cells. 2019 Jul 28;8(8):
pubmed: 31357692
Stem Cells Transl Med. 2023 Jan 30;12(1):17-25
pubmed: 36571216
Stem Cell Res Ther. 2022 Apr 4;13(1):146
pubmed: 35379361
Stem Cells Int. 2016;2016:3924858
pubmed: 27822228
PLoS One. 2012;7(4):e35036
pubmed: 22496888
J Transl Med. 2015 Sep 19;13:308
pubmed: 26386558
Blood Adv. 2017 Apr 25;1(11):628-643
pubmed: 28713871
Front Bioeng Biotechnol. 2022 Jan 13;9:837464
pubmed: 35096804
Cells. 2021 Dec 06;10(12):
pubmed: 34943941
Genome Biol. 2014;15(12):550
pubmed: 25516281
Stem Cell Res Ther. 2022 Aug 13;13(1):414
pubmed: 35964139
Front Immunol. 2022 Jul 06;13:874698
pubmed: 35874742
Int J Mol Sci. 2022 Feb 22;23(5):
pubmed: 35269568
J Cell Mol Med. 2018 Mar;22(3):1428-1442
pubmed: 29392844
Physiology (Bethesda). 2020 Mar 1;35(2):125-133
pubmed: 32027561
Stem Cell Res Ther. 2015 Apr 14;6:75
pubmed: 25890074
Wound Repair Regen. 2009 Mar-Apr;17(2):185-91
pubmed: 19320886
Circ Res. 2007 May 11;100(9):1249-60
pubmed: 17495232
Acc Chem Res. 2021 Mar 2;54(5):1080-1093
pubmed: 33596041
EMBO Rep. 2020 May 6;21(5):e48777
pubmed: 32162777
Mediators Inflamm. 2010;2010:865601
pubmed: 20628526
Stem Cell Res Ther. 2022 Sep 5;13(1):455
pubmed: 36064604
Cytotherapy. 2012 Nov;14(10):1171-81
pubmed: 22900957
J Cell Physiol. 2013 May;228(5):938-44
pubmed: 23042088
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Injury. 2022 Dec;53(12):3920-3929
pubmed: 36357245
Cytokine Growth Factor Rev. 2019 Jun;47:32-42
pubmed: 31129018
Dev Growth Differ. 2013 Apr;55(3):309-18
pubmed: 23452121
Cytometry A. 2018 Jan;93(1):19-31
pubmed: 29072818
Sci Rep. 2015 Mar 03;5:8718
pubmed: 25732721
J Invest Dermatol. 2011 Jul;131(7):1559-67
pubmed: 21451545
Int J Mol Sci. 2018 Jan 16;19(1):
pubmed: 29337886
Cell Stem Cell. 2021 Oct 7;28(10):1708-1725
pubmed: 34624232
Cell Metab. 2018 Jan 9;27(1):68-83
pubmed: 29320711
Cell Death Dis. 2020 Oct 15;11(10):863
pubmed: 33060560
J Diabetes Complications. 2018 Aug;32(8):795-798
pubmed: 29871782
Int J Mol Sci. 2020 Feb 14;21(4):
pubmed: 32075181
PLoS One. 2010 Apr 26;5(4):e10088
pubmed: 20436665
Int J Mol Sci. 2018 Oct 18;19(10):
pubmed: 30340330
Mol Ther. 2012 Jan;20(1):187-95
pubmed: 21934657
Int J Dev Biol. 2018;62(6-7-8):431-439
pubmed: 29938755
Stem Cells Transl Med. 2016 Dec;5(12):1620-1630
pubmed: 27460850